Move expands inoculation program as vaccination rates slow
US regulators on Monday authorized Pfizer and its partner BioNTech’s Covid vaccine for use in children as young as 12, widening the country’s inoculation program even as vaccination rates have slowed significantly.
The vaccine has been available under an emergency use authorization (EUA) to people as young as 16 in the United States. Today’s decision means the FDA is amending the EUA to include children aged 12 to 15. The vaccine makers said they had started the process for full approval for those ages last week.
Read the original article at The Guardian